Journal of Clinical Virology

Slides:



Advertisements
Similar presentations
Prevention, Treatment and Care of Hepatitis C among People Who Inject Drugs Jason Grebely, PhD Senior Lecturer Viral Hepatitis Clinical Research Program.
Advertisements

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Use of the insulin pump in treat cystic fibrosis related diabetes Dana S. Hardin, Julie Rice, Mark Rice, Randall Rosenblatt Journal of Cystic Fibrosis.
Journal of Clinical Virology
Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-γ-induced protein 10.
Human respiratory syncytial virus genomic and antigenic variants isolated in two hospitals during one epidemic, in Santiago, Chile  Vivian Luchsinger,
Volume 63, Issue 1, Pages (July 2015)
Journal of Clinical Virology
A qualitative PCR minipool strategy to screen for virologic failure and antiretroviral drug resistance in South African patients on first-line antiretroviral.
Élise Roy, Jean-François Boudreau, Jean-François Boivin 
Volume 61, Issue 4, Pages (October 2014)
Volume 50, Issue 4, Pages (April 2009)
Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the ‘accordion’ regimen?  Patrick Marcellin, E. Jenny Heathcote,
Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-γ-induced protein 10.
Clinician's Guide to Hepatitis C
R. Cavallo  Clinical Microbiology and Infection 
Chronic Hepatitis C Therapy: Changing the Rules of Duration
Volume 51, Issue 6, Pages (December 2009)
Volume 42, Issue 1, Pages (January 2005)
NS5A inhibitors in the treatment of hepatitis C
Cervical spine evaluation in the bluntly injured patient
Immigration and viral hepatitis
Hepatitis B and C virus-related carcinogenesis
Virological tools to diagnose and monitor hepatitis C virus infection
A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C Virus  Amit G. Singal, Michael.
Volume 69, Issue 2, Pages (August 2018)
Interferon λ 3 and 4 Genotyping Using High-Resolution Melt Curve Analysis Suitable for Multiple Clinical Sample Types  François M.J. Lamoury, Sofia Bartlett,
Hepatitis C core protein – The “core” of immune deception?
Volume 155, Issue 5, Pages e2 (November 2018)
No Differences in Achieving Hepatitis C Virus Care Milestones Between Patients Identified by Birth Cohort or Risk-Based Screening  Brianna L. Norton,
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Nghia H. Nguyen, Vincent Nguyen, Huy N. Trinh, Brian Lin, Mindie H
Hepatitis C Virus Infection in the Older Patient
Interpreting Hepatitis B Surface Antigen Levels: Useful Clinical Test or Just Another Confusing Assay?  Brian J. McMahon, MD, Brenna C. Simons, PhD  Clinical.
The allele 4 of neck region liver-lymph node-specific ICAM-3-grabbing integrin variant is associated with spontaneous clearance of hepatitis C virus and.
Controlled clinical trials in cystic fibrosis — are we doing better?
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Hepatitis C Virus Diagnosis and the Holy Grail
Volume 65, Issue 1, Pages (July 2016)
Volume 142, Issue 6, Pages (May 2012)
Volume 68, Issue 3, Pages (March 2018)
Hepatitis B and C virus-related carcinogenesis
Detection of, and frequent co-infection with, human bocavirus in faecal specimens from children in Wuhan, China  Y. Huang, P. Mao, H. Wang  Clinical Microbiology.
HCV epidemiology in high-risk groups and the risk of reinfection
A. A. Klein, T. Collier, J. Yeates, L. F. Miles, S. N. Fletcher, C
Chronic Hepatitis C Therapy: Changing the Rules of Duration
Volume 50, Issue 4, Pages (April 2009)
News & Notes Journal of Allergy and Clinical Immunology
Prevalence and Treatment of Hepatitis C Virus Genotypes 4, 5, and 6
Editorial Board Orthopedic Clinics Volume 48, Issue 3, (July 2017)
Editorial Board Orthopedic Clinics Volume 47, Issue 3, (July 2016)
Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: Analysis of a global dataset  J. Morgan Freiman, Jianing.
Immigration and viral hepatitis
Increased intrahepatic quasispecies heterogeneity correlates with off-treatment sustained response to nucleos(t)ide analogues in e antigen-positive chronic.
Volume 57, Issue 6, Pages (December 2012)
Volume 63, Issue 1, Pages (July 2015)
Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences  Zobair M. Younossi, Aybike Birerdinc,
Alessio Aghemo, Maria Francesca Donato  Gastroenterology 
Hepatitis C treatment in patients with kidney disease
Hepatitis C Genotypes: Current Trends and Future Implications
News & Notes Journal of Allergy and Clinical Immunology
Clinical Gastroenterology and Hepatology
Etanercept therapy in two patients with psoriasis and concomitant hepatitis C  Clara De Simone, MD, Andrea Paradisi, MD, Rodolfo Capizzi, MD, Angelo Carbone,
Footnotes1 Journal of Allergy and Clinical Immunology
Understanding How Hepatitis C Virus Builds Its Unctuous Home
News & Notes Journal of Allergy and Clinical Immunology
Fasiha Kanwal, Tuyen Hoang, Timothy Chrusciel, Jennifer R
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Journal of Clinical Virology Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post- treatment relapse  François M.J. Lamoury, Angelica Soker, Danica Martinez, Behzad Hajarizadeh, Evan B. Cunningham, Philip Cunningham, Philip Bruggmann, Graham R. Foster, Olav Dalgard, Markus Backmund, Brian Conway, Geert Robaeys, Tracy Swan, Gavin Cloherty, Pip Marks, Jason Grebely, Gregory J. Dore, Tanya L. Applegate  Journal of Clinical Virology  Volume 92, Pages 32-38 (July 2017) DOI: 10.1016/j.jcv.2017.05.007 Copyright © 2017 Terms and Conditions

Fig. 1 Correlation of HCVcAg and HCV RNA levels. Journal of Clinical Virology 2017 92, 32-38DOI: (10.1016/j.jcv.2017.05.007) Copyright © 2017 Terms and Conditions

Fig. 2 Distribution of HCV RNA and HCVcAg levels at each study timepoint. Journal of Clinical Virology 2017 92, 32-38DOI: (10.1016/j.jcv.2017.05.007) Copyright © 2017 Terms and Conditions

Fig. 3 Frequency of reactive HCVcAg across a range of HCV RNA levels. Journal of Clinical Virology 2017 92, 32-38DOI: (10.1016/j.jcv.2017.05.007) Copyright © 2017 Terms and Conditions

Fig. 4 HCV RNA and HCVcAg levels in a subset of patients with viral recurrence during treatment (grey box) and post-treatment follow-up. Journal of Clinical Virology 2017 92, 32-38DOI: (10.1016/j.jcv.2017.05.007) Copyright © 2017 Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.